An investigation for investors in BioLineRx Ltd. (NASDAQ:BLRX) shares over potential securities laws violations by BioLineRx Ltd. was announced.
San Diego, CA -- (SBWIRE) -- 10/07/2022 -- An investigation was announced for investors of BioLineRx Ltd. (NASDAQ: BLRX) shares over potential securities laws violations by BioLineRx Ltd.
Investors who purchased shares of BioLineRx Ltd. (NASDAQ: BLRX), have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by BioLineRx Ltd. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Israel based BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. BioLineRx Ltd.
BioLineRx Ltd.reported that its Net Loss declined from $30.02 million in 2020 to $27.05 million in 2021.
Shares of BioLineRx Ltd. (NASDAQ: BLRX) declined from $3.15 per share on October 15, 2021, to as low as $0.84 per share on September 26, 2022.
Those who purchased shares of BioLineRx Ltd. (NASDAQ: BLRX) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.